Clinical Trial Update: Heart Outcomes Prevention Evaluation-3 [Phase 4]

View source ↗

Summary

The document reports the completion of the Phase 4 Heart Outcomes Prevention Evaluation-3 trial evaluating cardiovascular outcomes and stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Stroke

Snippet

Sponsor: Population Health Research Institute | Conditions: Cardiovascular Disease, Stroke | Phase 4 | Status: COMPLETED